Yahoo News - Latest News & Headlines
FDA panel to focus on safety of Novartis gene therapy drug
The U.S. Food and Drug Administration will ask a panel of advisors to focus on the safety of Novartis AG's experimental gene therapy drug when it meets to review the product on Wednesday. The keenly anticipated preliminary review of the leukemia treatment, posted on the FDA's website on Monday, comes two days ahead of the advisory panel meeting, which will discuss the drug and vote on whether the benefits exceed the risks. If approved, the drug, tisagenlecleucel, would be the first gene therapy to be approved in the United States.
What Comes After ISIS?
The jihadi group's defeat in Mosul and Raqqa is about to usher in a new era — and new conflicts — across the Middle East.
Pakistan concludes probe into PM family's offshore accounts
ISLAMABAD (AP) — Pakistani authorities concluded an anti-graft probe into corruption allegations against Prime Minister Nawaz Sharif's family and the investigators' report was handed over to the Supreme Court on Monday, officials said.
Yahoo News - Latest News & Headlines
FDA panel to focus on safety of Novartis gene therapy drug
The U.S. Food and Drug Administration will ask a panel of advisors to focus on the safety of Novartis AG's experimental gene therapy drug when it meets to review the product on Wednesday. The keenly anticipated preliminary review of the leukemia treatment, posted on the FDA's website on Monday, comes two days ahead of the advisory panel meeting, which will discuss the drug and vote on whether the benefits exceed the risks. If approved, the drug, tisagenlecleucel, would be the first gene therapy to be approved in the United States.
What Comes After ISIS?
The jihadi group's defeat in Mosul and Raqqa is about to usher in a new era — and new conflicts — across the Middle East.
No comments:
Post a Comment